Delivery Order SPE2DB20D1100-SPE2DB25FE3C3
Award Date 8/27/25
Potential Completion Date 9/18/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $21,765.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 ml pen injections on August 12, 2025, with an ultimate completion date of September 3, 2025. This competitive award carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TREMFYA is a biologic medication used to treat autoimmune conditions including psoriasis and psoriatic arthritis,...
- The Defense Logistics Agency awarded a delivery order valued at $9,132.68 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. TREMFYA is a prescription biologic medication used to treat moderate to severe plaque psoriasis and...
- The Defense Logistics Agency awarded a $21,765.75 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of TREMFYA 200 mg/2 mL pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $14,539.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 mL syringes. This order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-set-aside competitive award. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TREMFYA is a biologic medication used to treat psoriasis and psoriatic arthritis, indicating this delivery supports...
- The Defense Logistics Agency awarded a $29,944.86 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/mL pharmaceutical product on August 7, 2025, with completion scheduled for August 8, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at the contractor's Conshohocken, Pennsylvania facility. TREMFYA is a biologic medication used primarily for treating moderate-to-severe plaque psoriasis and is being procured to...
- The Defense Logistics Agency awarded a $60,405.91 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes on August 7, 2025, with completion scheduled for August 8, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TREMFYA (guselkumab) is a biologic immunosuppressant used to treat plaque psoriasis and other inflammatory...
- The Defense Logistics Agency awarded a delivery order valued at $7,269.70 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes on August 18, 2025, with completion scheduled for August 19, 2025. This competitive award, which carries no set-aside designation, represents a firm fixed-price delivery order to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TREMFYA is a biologic medication used to treat plaque psoriasis and other inflammatory...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes valued at $7,683.48 on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside award to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. TREMFYA is a specialty immunosuppressant injection used to treat psoriasis and psoriatic arthritis, reflecting the...
- The Defense Logistics Agency awarded a $14,510.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for TREMFYA 200 mg/2 mL pen injections. This is a non-set-aside competitive award with a completion date of September 4, 2025, and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a $59,710.11 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes, with performance to be completed by July 31, 2025. This is a firm fixed price, non-competitive delivery order executed on July 30, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...